How Can AI Help Optimize Localization in a Decentralized World | Forum
As clinical-trial sponsors strive to bring new drugs to more markets faster and more efficiently, they must also improve the experience for patients and physicians within a changing regulatory environment.
All aspects of the product life cycle, from development and clinical trials through to post-marketing compliance and safety vigilance, must be tracked at increasing volumes and documented in very specific ways in every market, in line with local as well as regional and global marketing authorization and reporting standards.
Noncompliance in content can result in delay to market, recalls, fines and most importantly risk to patient safety, as well as associated reputational damage.
How Can AI Help Optimize Localization in a Decentralized World?
This Life Sciences forum will discuss the industry challenges and provide a roadmap to leveraging machine translation to optimize workflow for greater efficiency, consistency, security and savings. You will:
- Learn what’s driving the high growth in the life science industry and the operational pressures behind that growth
- Examine the stages and processes of the current decentralized workflow and assess their rising risks
- Adjust to the increasing demands posed by local, regional and global regulatory requirements
- Enable employees to collaborate more effectively and securely (such as protect patient information) between operations
- Improve patient and physician recruitment, retention, experience and satisfaction
- Translate large sets of documents, reports and marketing materials across local languages in the official corporate language faster and more accurately
Who should attend?
Pharma Companies and Clinical Research Organizations executives in a strategic or operational role in:
- The drug development lifecycle (R&D, Research, Regulatory, Clinical Trials)
- AI and MT Engineering; IT Security, Compliance and Platform Services
- Global marketing and localization with a focus on ensuring security and privacy
- Procurement and vendor management
The forum is reserved for client-side companies only. Agency, vendor and non-client registrations will not be accepted.
Wednesday, 28th September, 9:00-10:00am PST (17:00-18:00pm BST / UK)
9:00-9:05am PST Welcome by Slator, Andrew Smart
9:05-9:20am PST Keynote Presentation, Mark Shriner
9:20-9:40am PST Moderated Panel Discussion: Craig Brown, Bill Young, Mark Shriner
9:40-9:55am PST Audience Q&A
9:55-10:00am PST Closing Remarks, Andrew Smart
The Speakers and Panelists
Craig Brown, Vice President of Strategic Accounts, BIG Language Solutions
With more than 10 years’ experience delivering translation services to life science industries, Graig Brown, as part of BIG Language Solutions, leads a team of talented, multilingual sales professionals, solving challenges for global life science organizations. We believe high-quality translations contribute to positive health outcomes and commercial success.
Bill Young, Director of Life Science Sales, Systran
Bill Young is the Director of Life Science Sales at SYSTRAN Software in San Diego, where he provides solutions and recommendations for AI-based translation tools to Life Science companies to expand international corporate communications. He has a B.S. is Business Administration from UC Berkeley and MBA from George Washington University.
Mark Shriner, Strategic Sales Director, memoQ
Mark Shriner has held several leadership roles in the localization industry including CEO Asia Pacific for CLS Communication, and Managing Director Asia for thebigword. In his role as Strategic Sales Director for memoQ he supports the company’s market expansion efforts in the regulated industries and other strategic sales and marketing initiatives.
Andrew Smart, Co-Founder & Commercial Director, Slator
Andrew Smart is responsible for product development and pricing, online ad and research sales, and community building and event sponsorships. Prior to co-founding Slator, he has worked in the media, internet and finance industries including managing media businesses for Thomson Reuters, Fairfax Media and The Economist Group. He has an MBA in Finance and Investments from The George Washington University.
Systran is a pioneer and global leader in translation solutions. Since its foundation in 1968, Systran has been pioneering machine translation technology. The company leads the industry with a number of breakthrough innovations and solutions now commonly used by companies and consumers. With a strong focus on research and development, Systran is 50 years later, more innovative than ever.
Now introducing its Neural Machine Translation enterprise solution, Systran is bringing the capabilities of Neural translation to corporate users.